Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 6.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 002282 | K. Takase [Royaume-Uni] ; S C Horton [Royaume-Uni] ; A. Ganesha [Royaume-Uni] ; S. Das [Royaume-Uni] ; A. Mchugh [Royaume-Uni] ; P. Emery [Royaume-Uni] ; S. Savic [Royaume-Uni] ; M H Buch [Royaume-Uni] | What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort. |
| 002A28 | S. Das [Royaume-Uni] ; M. Fernandez Matilla [Espagne] ; S. Dass ; E. Vital [Royaume-Uni] ; P. Emery [Royaume-Uni] | THU0123 Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis |
| 002A46 | S. Das [Royaume-Uni] ; S. Horton [Royaume-Uni] ; E. Vital ; D. Bryer [Royaume-Uni] ; P. Emery [Royaume-Uni] ; M. Buch [Royaume-Uni] | THU0089 Response to abatacept and tocilizumab in patients who had failed rituximab– initial single centre experience |
| 003083 | S. C. Horton [Royaume-Uni] ; S. Das [Royaume-Uni] ; D. Bryer [Royaume-Uni] ; P. Emery [Royaume-Uni] ; M. H. Buch [Royaume-Uni] | AB0573 Tocilizumab use in a diverse patient population: Single-centre tertiary experience |
| 003128 | S. Das [Royaume-Uni] ; E. Vital [Royaume-Uni] ; S. Dass [Royaume-Uni] ; M. H. Buch [Royaume-Uni] ; A. C. Rawstron [Royaume-Uni] ; P. Emery [Royaume-Uni] | AB0527 Prediction of improving responses on repeat cycles of rituximab using B cell biomarkers |
| 003249 | K. Takase [Royaume-Uni] ; S. C. Horton [Royaume-Uni] ; A. Ganesha [Royaume-Uni] ; S. Das [Royaume-Uni] ; P. Emery [Royaume-Uni] ; S. Savic [Royaume-Uni] ; M. H. Buch [Royaume-Uni] | AB0274 What is the utility of routine ana testing in predicting development of biological dmard-induced lupus/vasculitis in patients with rheumatoid arthritis? |
| This area was generated with Dilib version V0.6.34. |  |